Unlocking the power of sensor data in type 2 diabetes care

By GABRIELLE GOLDBLATT Highly relevant, high-resolution data streams are essential to high-stakes decision making across industries. You wouldn’t expect an investment banker making deals without full market visibility or a grocery store to stock shelves without data on what’s selling and what’s not—so why are we not leaning more into data-driven approaches in healthcare?  Sensor-based…

Read More

A Primer on Health Equity Research

According to the World Health Organization, “Three distinguishing features, when combined, turn mere variations or differences in health into a social inequity in health. They are systematic, socially produced (and therefore modifiable) and unfair. That is how an ISPOR Special Interest Group Report by Griffiths et al. (2025) begins. The health equity primer provides and…

Read More

Links

Tyler Cowen on the price of Ozempic.Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban life expectancy.Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?

Read More

CMS comes out with List of Drugs for 2027 Price Negotiation

From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2027“: On January 17, 2025, CMS announced the selection of the below list of 15 drugs covered under Medicare Part D for the second cycle of negotiations (initial price applicability year 2027), based on total gross covered prescription drug…

Read More